542 related articles for article (PubMed ID: 15472895)
41. Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.
von Deimling A; Bender B; Jahnke R; Waha A; Kraus J; Albrecht S; Wellenreuther R; Fassbender F; Nagel J; Menon AG
Cancer Res; 1994 Mar; 54(6):1397-401. PubMed ID: 8137236
[TBL] [Abstract][Full Text] [Related]
42. MRS of oligodendroglial tumors: correlation with histopathology and genetic subtypes.
Jenkinson MD; Smith TS; Joyce K; Fildes D; du Plessis DG; Warnke PC; Walker C
Neurology; 2005 Jun; 64(12):2085-9. PubMed ID: 15985578
[TBL] [Abstract][Full Text] [Related]
43. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.
Bigner SH; Matthews MR; Rasheed BK; Wiltshire RN; Friedman HS; Friedman AH; Stenzel TT; Dawes DM; McLendon RE; Bigner DD
Am J Pathol; 1999 Aug; 155(2):375-86. PubMed ID: 10433931
[TBL] [Abstract][Full Text] [Related]
44. Recurrent gain of chromosome arm 7q in low-grade astrocytic tumors studied by comparative genomic hybridization.
Schröck E; Blume C; Meffert MC; du Manoir S; Bersch W; Kiessling M; Lozanowa T; Thiel G; Witkowski R; Ried T; Cremer T
Genes Chromosomes Cancer; 1996 Apr; 15(4):199-205. PubMed ID: 8703845
[TBL] [Abstract][Full Text] [Related]
45. Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas.
Kreiger PA; Okada Y; Simon S; Rorke LB; Louis DN; Golden JA
Acta Neuropathol; 2005 Apr; 109(4):387-92. PubMed ID: 15739101
[TBL] [Abstract][Full Text] [Related]
46. Glioneuronal tumor with neuropil-like islands (GTNI): a report of 8 cases with chromosome 1p/19q deletion analysis.
Barbashina V; Salazar P; Ladanyi M; Rosenblum MK; Edgar MA
Am J Surg Pathol; 2007 Aug; 31(8):1196-202. PubMed ID: 17667543
[TBL] [Abstract][Full Text] [Related]
47. Oligodendrogliomas: clinical significance of 1p and 19q chromosomal deletions.
Sonabend AM; Lesniak MS
Expert Rev Neurother; 2005 Nov; 5(6 Suppl):S25-32. PubMed ID: 16274268
[TBL] [Abstract][Full Text] [Related]
48. [Histological and molecular classification of gliomas].
Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
[TBL] [Abstract][Full Text] [Related]
49. MR imaging characteristics of oligodendroglial tumors with assessment of 1p/19q deletion status.
Sherman JH; Prevedello DM; Shah L; Raghavan P; Pouratian N; Starke RM; Lopes MB; Shaffrey ME; Schiff D
Acta Neurochir (Wien); 2010 Nov; 152(11):1827-34. PubMed ID: 20711790
[TBL] [Abstract][Full Text] [Related]
50. Molecular genetic evidence for subtypes of oligoastrocytomas.
Maintz D; Fiedler K; Koopmann J; Rollbrocker B; Nechev S; Lenartz D; Stangl AP; Louis DN; Schramm J; Wiestler OD; von Deimling A
J Neuropathol Exp Neurol; 1997 Oct; 56(10):1098-104. PubMed ID: 9329453
[TBL] [Abstract][Full Text] [Related]
51. Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms.
Zlatescu MC; TehraniYazdi A; Sasaki H; Megyesi JF; Betensky RA; Louis DN; Cairncross JG
Cancer Res; 2001 Sep; 61(18):6713-5. PubMed ID: 11559541
[TBL] [Abstract][Full Text] [Related]
52. Chromosomal aberrations of malignant pleural effusions of lung adenocarcinoma: different cytogenetic changes are correlated with genders and smoking habits.
Yen CC; Liang SC; Jong YJ; Chen YJ; Lin CH; Chen YM; Wu YC; Su WC; Huang CY; Tseng SW; Whang-Peng J
Lung Cancer; 2007 Sep; 57(3):292-301. PubMed ID: 17553591
[TBL] [Abstract][Full Text] [Related]
53. Chromosome 1p allelic loss by fluorescence in situ hybridization is not observed in dysembryoplastic neuroepithelial tumors.
Prayson RA; Castilla EA; Hartke M; Pettay J; Tubbs RR; Barnett GH
Am J Clin Pathol; 2002 Oct; 118(4):512-7. PubMed ID: 12375636
[TBL] [Abstract][Full Text] [Related]
54. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas.
Speicher MR; Howe C; Crotty P; du Manoir S; Costa J; Ward DC
Cancer Res; 1995 Mar; 55(5):1010-3. PubMed ID: 7866983
[TBL] [Abstract][Full Text] [Related]
55. Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials.
Brat DJ; Seiferheld WF; Perry A; Hammond EH; Murray KJ; Schulsinger AR; Mehta MP; Curran WJ;
Neuro Oncol; 2004 Apr; 6(2):96-103. PubMed ID: 15134623
[TBL] [Abstract][Full Text] [Related]
56. Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival.
Felsberg J; Erkwoh A; Sabel MC; Kirsch L; Fimmers R; Blaschke B; Schlegel U; Schramm J; Wiestler OD; Reifenberger G
Brain Pathol; 2004 Apr; 14(2):121-30. PubMed ID: 15193024
[TBL] [Abstract][Full Text] [Related]
57. Caveolin 1 expression independently predicts shorter survival in oligodendrogliomas.
Senetta R; Trevisan E; Rudà R; Maldi E; Molinaro L; Lefranc F; Chiusa L; Lanotte M; Soffietti R; Cassoni P
J Neuropathol Exp Neurol; 2009 Apr; 68(4):425-31. PubMed ID: 19287309
[TBL] [Abstract][Full Text] [Related]
58. Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas.
Fallon KB; Palmer CA; Roth KA; Nabors LB; Wang W; Carpenter M; Banerjee R; Forsyth P; Rich K; Perry A
J Neuropathol Exp Neurol; 2004 Apr; 63(4):314-22. PubMed ID: 15099021
[TBL] [Abstract][Full Text] [Related]
59. Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma.
Perry A; Aldape KD; George DH; Burger PC
Cancer; 2004 Nov; 101(10):2318-26. PubMed ID: 15470710
[TBL] [Abstract][Full Text] [Related]
60. Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling.
Tews B; Felsberg J; Hartmann C; Kunitz A; Hahn M; Toedt G; Neben K; Hummerich L; von Deimling A; Reifenberger G; Lichter P
Int J Cancer; 2006 Aug; 119(4):792-800. PubMed ID: 16550607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
